Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mangoral liver MRI in severe renal impairment
2019-001599-12Phase 3Completed
- Sponsor
- Ascelia Pharma AB
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Mangoral in focal liver lesion, sponsored by Ascelia Pharma AB. Primary endpoint: Visualization of detected focal liver lesions in combined MRI vs unenhanced MRI. Started Jul 2019; status: completed.
02
Drugs
Mangoral
03
Conditions
focal liver lesion
Beyond the preview
Go deeper on 2019-001599-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001599-12.